MANNATECH INC Payments to Acquire Investments
MANNATECH INC (MTEX) reported Payments to Acquire Investments of $0 for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2011-03-10
- MANNATECH INC payments to acquire investments for the quarter ending 2009-12-31 was $0.00.
- MANNATECH INC payments to acquire investments for the quarter ending 2008-12-31 was $0.00.
- MANNATECH INC payments to acquire investments for fiscal 2010 was $0.00.
- MANNATECH INC payments to acquire investments for fiscal 2009 was $0.00, a 100.00% decline from fiscal 2008.
- MANNATECH INC payments to acquire investments for fiscal 2008 was $7.40M.
- MANNATECH INC payments to acquire investments for fiscal 2007 was $0.00.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|
| 2010-12-31 | $0.00 10-K · filed 2011-03-10 | ||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2011-03-10 | $0.00 10-K · filed 2011-03-10 | |
| 2009-09-30 | $0.00 10-Q/A · filed 2009-11-05 | ||
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2011-03-10 | $7.40M 10-K · filed 2011-03-10 | |
| 2008-09-30 | $7.40M 10-Q/A · filed 2009-11-05 | ||
| 2007-12-31 | $0.00 10-K · filed 2010-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |